[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.147.238.168. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Correspondence
May 01, 2008

Classic Mediterranean Kaposi’s Sarcoma Regression With Sirolimus Treatment

Arch Dermatol. 2008;144(5):692-693. doi:10.1001/archderm.144.5.692

Replacement of mycophenolate mofetil, cyclosporine, or tacrolimus by sirolimus results in regression of Kaposi's sarcoma (KS) in organ transplant recipients.13 In these patients, clearance from KS might result either from reduced immunosuppression or from the direct antiangiogenic effects of sirolimus.

First Page Preview View Large
First page PDF preview
First page PDF preview
×